Defendant: Lupin Limited
Court: US-DIS-DED
Date: May 20, 2011
Docket: 1:11cv439
Patent infringement action. Defendant Lupin is seeking FDA approval to make and sell generic 0.3 percent gatifloxacin ophthalmic solution before expiration of U.S. Patent Nos. 6,333,045 and 5,880,283.
- Patent_111cv439 [171.09 kB]
- Complaint_111cv439 [133.51 kB]
Share